Synapse

← Therapeutic Advances in Reproductive Health

Papers in Therapeutic Advances in Reproductive Health

Page 2 · newest first

  1. The role of socioeconomic status in uterine fibroid awareness and treatment: a narrative reviewTherapeutic Advances in Reproductive Health · 2024
  2. The role of artificial intelligence in transforming maternity services in Africa: prospects and challengesTherapeutic Advances in Reproductive Health · 2024
  3. Comparing visual estimation and hematocrit change in the assessment of blood loss among women undergoing cesarean delivery in a tertiary facility in northern UgandaTherapeutic Advances in Reproductive Health · 2024
  4. Assessment of reproductive knowledge among young adults utilizing Amazon mechanical Turk surveyTherapeutic Advances in Reproductive Health · 2024
  5. Reproductive and oncologic outcomes in young women with uterine sarcoma undergoing fertility-sparing treatment: a systematic reviewTherapeutic Advances in Reproductive Health · 2024
  6. Chlamydia trachomatis infections in Kenya – sexually transmitted and ocular infections: a scoping reviewTherapeutic Advances in Reproductive Health · 2024
  7. Association between pathological positivity rate of endometriosis, demographics, and concomitant gynecological conditionsTherapeutic Advances in Reproductive Health · 2024
  8. Association of vitamin A with gestational diabetes and thyroid disorders in pregnancy and their influence on maternal, fetal, and neonatal outcomesTherapeutic Advances in Reproductive Health · 2024
  9. Women’s willingness for cervical cancer screening and associated factors among women attending health services in Addis Ababa, EthiopiaTherapeutic Advances in Reproductive Health · 2024
  10. Relationship between chronic endometritis and fallopian tube obstruction and its influence on pregnancy outcome after fallopian tubal recanalizationTherapeutic Advances in Reproductive Health · 2024
  11. Delay in seeking treatment and associated factors among women with pelvic organ prolapse in Bale Zone, Southeast Ethiopia: a hospital-based cross-sectional studyTherapeutic Advances in Reproductive Health · 2024
  12. Comparison of efficacy between levonorgestrel intrauterine system and dienogest in adenomyosis: a randomized clinical trialTherapeutic Advances in Reproductive Health · 2024
  13. Ethnic disparities in the incidence of gynecologic malignancies among Israeli Women of Arab and Jewish Ethnicity: a 10-year study (2010–2019)Therapeutic Advances in Reproductive Health · 2023
  14. Neurokinin receptor antagonists as potential non-hormonal treatments for vasomotor symptoms of menopauseTherapeutic Advances in Reproductive Health · 2023
  15. Reversible interventions for menstrual management in adolescents and young adults with gender incongruenceTherapeutic Advances in Reproductive Health · 2023
  16. Advances in contraception: vaginal contraceptive ringsTherapeutic Advances in Reproductive Health · 2023
  17. Effects of sperm processing techniques on IVF pregnancy rates: a mini-reviewTherapeutic Advances in Reproductive Health · 2023
  18. Emerging concepts in male contraception: a narrative review of novel, hormonal and non-hormonal optionsTherapeutic Advances in Reproductive Health · 2023
  19. Intralipid infusion therapy as an adjunct treatment in women experiencing adenomyosis-related infertilityTherapeutic Advances in Reproductive Health · 2023
  20. Risk of ovarian hyperstimulation syndrome in women with malignancies undergoing treatment with long-acting gonadotropin-releasing hormone agonist after controlled ovarian hyperstimulation for fertility preservation: a systematic reviewTherapeutic Advances in Reproductive Health · 2023
  21. Evaluation of predictor factors of psychological distress in women with unexplained infertilityTherapeutic Advances in Reproductive Health · 2022
  22. A rational diagnostic approach to the “phantom hCG” and other clinical scenarios in which a patient is thought to be pregnant but is notTherapeutic Advances in Reproductive Health · 2021
  23. Subarachnoid haemorrhage in pregnancy after in vitro fertilisation with egg donation: a case report and review of the literatureTherapeutic Advances in Reproductive Health · 2021
  24. The role of midwives and obstetrical nurses in the promotion of healthy lifestyle during pregnancyTherapeutic Advances in Reproductive Health · 2021
  25. Mitochondrial enrichment in infertile patients: a review of different mitochondrial replacement therapiesTherapeutic Advances in Reproductive Health · 2021
  26. A review of maternal overweight and obesity and its impact on cardiometabolic outcomes during pregnancy and postpartumTherapeutic Advances in Reproductive Health · 2021
  27. Type and dose of gonadotropins in poor ovarian responders: does it matter?Therapeutic Advances in Reproductive Health · 2021
  28. Human growth hormone use in poor ovarian response – caution and opportunitiesTherapeutic Advances in Reproductive Health · 2021
  29. Update on the management of poor ovarian response in IVF: the shift from Bologna criteria to the Poseidon conceptTherapeutic Advances in Reproductive Health · 2020
  30. Characteristics of polycystic ovary syndrome throughout lifeTherapeutic Advances in Reproductive Health · 2020
  31. Controversies in the diagnosis of polycystic ovary syndromeTherapeutic Advances in Reproductive Health · 2020
  32. Intimate partner violence among postpartum women at a teaching hospital in Nigeria’s Federal Capital City: pattern and materno-fetal outcomesTherapeutic Advances in Reproductive Health · 2020
  33. Ejaculatory abstinence in semen analysis: does it make any sense?Therapeutic Advances in Reproductive Health · 2020
  34. The insulin signaling pathway is dysregulated in cumulus cells from obese, infertile women with polycystic ovarian syndrome with an absence of clinical insulin resistanceTherapeutic Advances in Reproductive Health · 2020
  35. Conception rates after fluoroscopy-guided fallopian tubal cannulation: an alternative to in vitro fertilization for patients with tubal occlusionTherapeutic Advances in Reproductive Health · 2020
  36. The clinical use of time-lapse in human-assisted reproductionTherapeutic Advances in Reproductive Health · 2020
  37. Reaching women with obesity to support weight loss before pregnancy: feasibility and qualitative assessmentTherapeutic Advances in Reproductive Health · 2020
  38. The obligate need for accuracy in reporting preclinical studies relevant to clinical trials: autologous germline mitochondrial supplementation for assisted human reproduction as a case studyTherapeutic Advances in Reproductive Health · 2020
  39. Patient perspectives and experiences with in vitro fertilization and genetic testing optionsTherapeutic Advances in Reproductive Health · 2020
  40. Laboratory and clinical management of leukocytospermia and hematospermia: a reviewTherapeutic Advances in Reproductive Health · 2020
  41. Risk factors for women’s non-utilization of decentralized primary health care facilities for postnatal care in rural western EthiopiaTherapeutic Advances in Reproductive Health · 2020
  42. Attitudes and experiences of health care professionals when caring for transgender men undergoing fertility preservation by egg freezing: a qualitative studyTherapeutic Advances in Reproductive Health · 2020
  43. Serum estradiol levels in infertile men with non-obstructive azoospermiaTherapeutic Advances in Reproductive Health · 2020
  44. Surgical adhesions among women undergoing laparoscopic gynecological surgery with or without adhesiolysis – prevalence, severity, and implications: retrospective cohort study at a University HospitalTherapeutic Advances in Reproductive Health · 2020
  45. What is new in the landscape of insulin-sensitizing agents for polycystic ovary syndrome treatmentTherapeutic Advances in Reproductive Health · 2020